Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for High Breast Density in Postmenopausal Women
NCT00280930Phase 2Unknown
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Dana-Farber Cancer Institute. Status: unknown.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00280930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280930.